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Abstract
Aim: Our retrospective study compared the results of three surgical procedures for correction of pediatric
vesicoureteral reflux (VUR): open Cohen, laparoscopic Lich-Gregoir reimplantation (LEVUR), and endoscopic
subureteric injection (STING) procedure.
Methods: We analyzed 90 patients (50 girls, 40 boys, average age 4.86 years) operated in two centers of
pediatric surgery for VUR. Exclusion criteria were Grade 1 VUR, Grade 5 VUR with megaureters requiring
ureteral tapering, secondary VUR, and patients already operated for VUR. Thirty patients underwent Cohen,
30 LEVUR, and 30 STING procedure. Follow-up included renal ultrasonography and voiding cystourethro-
graphy 6 months postoperatively. The statistical analysis was performed using v2 Pearson and Fisher tests.
Results: Operative time was shorter using STING either for unilateral or bilateral correction (P= .001). Hos-
pitalization was statistically shorter using STING and LEVUR compared to Cohen (P = .001). The pain scores
were worse after Cohen (P= .001). Analgesic requirements were higher after Cohen (P = .001). Reflux per-
sistence was higher after STING (10 cases versus 5 Cohen and 4 LEVUR). Cohen presented more compli-
cations compared to LEVUR and STING (P= .001). Intraoperative costs were higher for STING procedure
(P= .001), while hospitalization costs were significantly higher for Cohen procedure (P= .001).
Conclusions: In children affected by VUR, open Cohen and LEVUR reported a higher success rate than STING
procedure. However, Cohen procedure had a very long and painful hospital stay, more complications, more
analgesic requirements compared to STING and LEVUR. Comparing the three techniques, it seems that
LEVUR presents a high success rate similar to the Cohen procedure, but in addition, it presents the same
advantages of STING procedure with no postoperative pain and a lower postoperative morbidity.
Introduction
Vesicoureteral reflux (VUR) represents one of themost significant risk factors for acute pyelonephritis in
children.1 The aim of any treatment in children with VUR is
the prevention of renal injury, symptomatic pyelonephritis, or
other complications of reflux that lead to renal scarring, with
decreased renal function.2–4 In recent years, the evolution of
the surgical treatment recommendations permits to have
several techniques and approaches available, starting from
the classic open way using intravesical ureteral reimplantation
according to Cohen or Politano, the endoscopic subureteric
injection (STING) procedure, and recently, laparoscopic ex-
travesical ureteral reimplantation according to Lich-Gregoir or
LEVUR.5–8
In general, the choice of the therapy depends not only
on the grade of reflux but also on ipsilateral renal func-
tion, bladder capacity and function, associated ureterorenal
anomalies, age, compliance, parental preference, and sur-
geon’s preference and experience.9,10 Over the last decades,
various surgical methods have been described to correct
VUR in children. The Cohen, Politano-Leadbetter, and
Lich-Gregoir procedures have gained the greatest popularity
among the intra- and extravesical techniques used in daily
practice.11–14 Utilizing the same principle of lengthening the
intramural ureter with a submucosal tunnel, all open surgical
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methods to correct VUR in children have been shown to
be safe with few complications but may be associated with
increased pain and length of hospital stay.15–17 Minimally
invasive procedures such as endoscopic injection of bulk-
ing agents and laparoscopic techniques have demonstrated
equivalent good long-term results compared to open sur-
gery.18–20 With excellent success rates of greater than 90%
reported with the current open techniques for antireflux sur-
gery, many surgeons focus on the minimization of morbidity
of the surgical procedure used for the treatment of VUR.21
Proponents of the Lich-Gregoir technique embark on this
surgical approach due to diminished postoperative pain and
discomfort resulting from the elimination of postoperative
catheter and drainage, as well as the avoidance of open cy-
stotomy and trigonal dissection.22,23
The purpose of this article is to compare the results of the
three different surgical techniques currently in use for the
correction of VUR as follows: the open technique (Cohen),
the endoscopic procedure (STING), and the laparoscopic ex-
travesical ureteral reimplantation according to Lich-Gregoir
(LEVUR).
Patients and Methods
We analyzed the records of 90 patients operated in two
European centers of pediatric surgery in the period January
2012–June 2015 for primary VUR into a solitary collecting
system.
Thirty patients had bilateral reflux. For this reason, a total
of 120 ureteral units have been treated. Exclusion criteria were
as follows: Grade 1 VUR, Grade 5 VUR with megaureters re-
quiring ureteral tapering, secondary VUR, and patients already
operated for VUR. We excluded also patients with concomitant
significant anatomical abnormalities (e.g., large paraureteral
diverticula, ectopic ureters, duplex systems) that could have
changed the decision of surgery and the success rates as well.
We included patients with Grade 2–5 VUR not requiring
ureteral tapering.
Among the 90 patients, there were 50 girls and 40 boys
with an average age of 4.86 years (range 11 months–12 years)
and an average weight of 18.5Kg (range 6–59Kg). We en-
rolled with retrospective method 30 patients for each group as
follows: 30 patients operated using the intravesical open
Cohen technique, 30 using LEVUR, and 30 using endoscopic
STING procedure.
In STING group, 50% of patients had Grade 2 VUR and
only 6.7% had Grade 5 VUR, while in Cohen group, 60% of
patients had Grade 5 VUR and 0% Grade 2 VUR, and in
LEVUR group, the majority of patients had Grade 3–4 VUR.
The procedures were performed by three expert surgeons
from two different institutions.
All the patients were operated under general anesthesia.
Patients who underwent STING and unilateral LEVUR pro-
cedures had no bladder catheter, ureteral stents, or drainage
during the postoperative period compared to patients oper-
ated with Cohen technique. We preferred to leave a bladder
catheter for the first 24 hours after surgery in patients who
underwent bilateral LEVUR repairs.
In laparoscopy, we adopted a 5-mm 30 optic and two
3-mm trocars and the bladder was suspended to the abdom-
inal wall using a transparietal stitch to better expose the ve-
sicoureteral junction (VUJ). The distal ureter was isolated
and dissected toward the VUJ. The peritoneumwas incised to
expose the muscular wall of the bladder and create a lateral
tunnel. The ureter was placed in the newly created tunnel and
the detrusor muscle was reapproximated.
As for the endoscopic procedure, we adopted the sub-
ureteric injection (STING) method in all patients. We used a
9.5-mm operative cystoscope. Under direct vision, a needle
was introduced under the bladder mucosa, 2–3mm below the
affected ureteral orifice at the 6 o’clock position. The needle
was advanced into the lamina propria in the submucosal part
of the ureter and the bulking agent was injected. We used
dextranomer/hyaluronic acid copolymer (Dx/HA) as bulk-
ing agent. We preferred it since it is easy to inject, is biode-
gradable with stable implant volume, and is currently the
first-choice injectable agent due to its safety and efficacy.
As for the open Cohen procedure, all the patients received
a classic Pfannenstiel incision and an open cystotomy was
performed. A cross-trigonal tunnel was created bringing the
ureter to the contralateral side, and a bladder catheter, a
drain in the prevesical space, ureteral stents, and a vesi-
costomy tube were left at the end of the operation. We
preferred to leave both a bladder catheter and a vesicostomy
in the open group because in our experience, the bladder
catheters were often obstructed due to hematuria. To avoid
the formation of blood clots, we performed also washing of
bladder with saline through the vesicostomy, above all in the
first postoperative period.
Statistical analysis was carried out by using the Statistical
Package for Social Sciences (SPSS, Inc., Chicago, IL), version
13.0. Significance was defined as P< .05. The categorical
variables were compared using v2 Pearson and Fisher tests.
The ordinal variables were compared using the Student’s two-
tailed type 2 t-test and nonparametric test, Kruskal–Wallis.
Data are presented as average – standard deviation (SD).
Follow-up evaluation (average 2.6 years) included clinical
examination, renal ultrasonography, and voiding cystoure-
thrography 6 months postoperatively in all the operated
children.
The groups were compared in regard to operative time,
hospitalization, duration of hematuria, postoperative dis-
comfort and pain, analgesic requirements, reflux persistence,
complications, and intraoperative and postoperative hospi-
talization costs.
The study received the approval of the ethics committee.
Results
Sixty patients received unilateral treatment (18 patients
underwent STING, 22 patients underwent LEVUR, and 20
patients underwent Cohen reimplantation) and 30 patients
received bilateral treatment (12 patients underwent STING,
8 patients underwent LEVUR, and 10 patients underwent
Cohen reimplantation).
In regard to indications for surgery, 71 patients (78.8%)
showed recurrent febrile urinary tract infections (UTIs) be-
fore surgery (1 episode minimum, 11 episodes maximum,
3.11 median – SD 2.601), 58 patients (81.7%) presented with
breakthrough UTIs despite the administration of continuous
antibiotic prophylaxis (CAP), while 13 patients (18.3%)
presented with UTIs soon after the interruption of CAP. The
remaining 19 patients showed new renal scarring and/or a
marked decrease in renal function (>20% compared to the
2 ESPOSITO ET AL.
function of contralateral kidney) at dimercaptosuccinic acid
(DMSA) renal scan routine evaluation, and they were can-
didates for surgical correction of VUR. Dysfunctional
voiding was diagnosed in 7 patients (4 underwent STING, 1
underwent LEVUR, and 2 underwent Cohen). These patients
were typical ‘‘infrequent voiders’’ with an average number of
three micturitions per day, and after surgery, they were in-
structed to practice frequent bladder emptying by voiding
every 2 hours.
All patients’ baseline demographics are reported in Table 1.
All the procedures were completed without intraoperative
complications and no conversion to another type of procedure
was performed. The follow-up varied between 1 and 5 years
(average 2.7 years in STING group, 2.9 years in LEVUR
group, and 3.1 years in Cohen group).
Operative time was statistically significantly shorter using
STING compared to the other techniques either for unilateral
(16.50 – SD 2.013 minutes [STING] versus 95.50 – SD
33.59 minutes [LEVUR] versus 109.35 – SD 17.73 minutes
[Cohen]; P = .001) or bilateral corrections (26.39 – SD 5.013
minutes [STING] versus 128.60 – SD 36.58 minutes [LEVUR]
versus 149.15 – SD 28.75 minutes [Cohen]; P= .001).
Hospitalization was statistically shorter using STING and
LEVUR compared to Cohen (1.11 days – SD 0.567 [STING]
versus 2.41 days – SD 0.867 [LEVUR] versus 12.58 days –
SD 4.263 [Cohen]; P= .001; Table 2).
None of the patients who underwent STING and unilateral
LEVUR procedures had a bladder catheter during the post-
operative period, while only 8 patients who underwent
bilateral LEVUR repair had a bladder catheter for the first
24 hours after surgery compared to 27 patients operated with
Cohen technique (P= .001). Analgesic requirements (para-
cetamol 15mg/kg; tramadol 2mg/kg) were higher after Co-
hen reimplantation compared to STING and LEVUR
(4.83 days – SD 2.87 versus 1.00 day – SD 0.29 versus
1.30 days – SD 0.59; P = .001; Table 2).
In Cohen group, we removed the drains on the sixth or
seventh postoperative day beginning from the ureteral drains,
and then the bladder catheter, the vesicostomy tube, and
finally, the drain in the prevesical space were removed. Before
removing the ureteral drains, we injected methylene blue dye
in the ureteral drain, and then we closed it to verify the ab-
sence of ureteral edema if we observed the passage of the blue
dye into the bladder. Sometimes, we repeated these tests with
blue dye two to three times before removing the drains due to
the edema of the reimplanted ureter, and this could explain
the long hospitalization of the patients who underwent open
Cohen procedure, although the average analgesic require-
ment was only 4.83 days.
We evaluated the postoperative comfort and pain in all
patients of each group during the first postoperative day
through the vascular analog scale (VAS) Numeric Pain Dis-
tress Scale24, and we created three categories of comfort as
follows: very good (0–3 VAS score), good (3–7 VAS score),
and bad (7–10 VAS score). The objective pain and discomfort
scores were worse after Cohen procedure (P= .001; Table 3).
In regard to postoperative complications, Cohen presented
more complications compared with LEVUR and STING [11
(36.6%) versus 2 (6.7%); P = .001].
All complications except one were classified as II grade
according to the Clavien–Dindo grading system25; in fact,
Table 1. Patients’ Baseline Demographics
Average age at surgery (years) 4.86
Average weight (Kgs) 18.5
Male 40
Female 50
M/F ratio 0.8
STING
(n = 30)
LEVUR
(n= 30)
COHEN
(n = 30)
Grade 2 VUR 15 (50%) 5 (16.6%) 0
Grade 3 VUR 7 (23.3%) 8 (26.6%) 2 (6.7%)
Grade 4 VUR 6 (20%) 13 (43.4%) 10 (33.3%)
Grade 5 VUR 2 (6.7%) 4 (13.4%) 18 (60%)
Unilateral repair 18 22 20
Bilateral repair 12 8 10
Bladder dysfunction 4 1 2
Average follow-up
(years)
2.7 2.9 3.1
Indications for
surgery
Breakthrough UTIs
despite CAP
22 17 19
Breakthrough UTIs
without CAP
4 5 4
Renal scarring at
DMSA scan
4 8 7
CAP, continuous antibiotic prophylaxis; DMSA, dimercaptosucci-
nic acid; LEVUR, laparoscopic Lich-Gregoir reimplantation; STING,
subureteric injection; UTI, urinary tract infection; VUR, vesicoureteral
reflux.
Table 2. Postoperative Management for Each Group
STING LEVUR Cohen
STING vs.
LEVUR (P)
STING vs.
Cohen (P)
LEVUR vs.
Cohen (P)
Bladder catheter 0 8 (26.6%) 27 (90%) .001 .001 .001
Vesicostomy tube 0 0 23 (76.6%) .001 .001 .001
Anticholinergic drugs 0 0 2 (6.66%) ns ns ns
Analgesic requirements (days) 1.00 – 0.29 1.30 – 0.59 4.83 – 2.87 ns .001 .001
Operating time unilateral
VUR (minutes)
16.50 – 2.013 95.50 – 33.59 109.35– 17.73 .001 .001 .049
Operating time bilateral
VUR (minutes)
26.39 – 5.013 128.60 – 36.58 149.15– 28.75 .001 .001 .049
Hospitalization (days) 1.11 – 0.567 2.41 – 0.867 12.58– 4.263 .001 .001 .030
LEVUR, laparoscopic Lich-Gregoir reimplantation; STING, subureteric injection; VUR, vesicoureteral reflux.
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they resolved spontaneously or after medical therapy, with-
out the need of a new surgical procedure. Only one patient
who underwent Cohen was reoperated because of an acute
ureteral obstruction in the postoperative period (3 days after
initial surgery) [III-b grade].
As for postoperativeUTIs, only four patients (4.4%) showed
long-term recurrent UTIs, and they were treated with CAP,
without significant difference from each group. Hematuria and
stranguria occurred only after intravesical reimplantation
(P= .001). Reflux persistence was higher after STING com-
pared with LEVUR and Cohen (10 cases versus 5 Cohen and 4
LEVUR, P= .001; Table 4).
In addition, we analyzed both intraoperative costs (materi-
als, labor, time) and postoperative hospitalization costs for all
procedures, and we found that the intraoperative costs were
significantly higher using STING compared to the other
techniques (P= .001), and this differencewas mainly related to
the costs of the bulking agent used. The hospitalization costs
were significantly higher after Cohen procedure (P= .001;
Table 4).
Discussion
In the past 30 years, the therapeutic approach to children
with vesicoureteral reflux (VUR) has undergone a dramatic
evolution frommainly surgery, as soon as VURwas detected,
toward a conservative approach with CAP, to a minimally
invasive approach using endoscopic or laparoscopic ap-
proach, or to an active surveillance without prophylaxis in
asymptomatic patients without infections.3,9
Analyzing the international literature, it is evident that the
treatment selection and decision for treating VUR in a child is
an individualized process.3 As for currently available surgi-
cal approaches, there are the classic open approach using
Cohen or Politano-Lead better ureteral reimplantation,7 the
endoscopic approach using bulking agents,18 and the lap-
aroscopic approach using extravesical reimplantation ac-
cording to Lich-Gregoir23,26 or laparoscopic intravesical
reimplantation described by Yeung and Valla.20
Considering that there are scanty comparative reports in the
international literature and considering that in our centers, we
perform the three different approaches of open surgery, en-
doscopy, and laparoscopy, we decided to plan this study to
compare the results of the three different techniques and to
give more objective criteria when a surgical correction is in-
dicated.As for the criteria of exclusion of this study, they are as
follows: Grade 1 VUR for which there is no indication for
surgery and Grade 5 VUR with megaureters in which ure-
teral tapering is necessary, and it is challenging and time-
consuming to perform it laparoscopically. In addition, we
also excluded patients already operated for VUR and patients
with concomitant significant anatomical abnormalities (e.g.,
large paraureteral diverticula, ectopic ureters, and duplex
systems) that could have changed the decision of surgery and
the success rates as well. We decided to analyze several pa-
rameters in this study. Not only the success rate but also
postoperative course, hospitalization, complications, and
costs because we noted in our experience that there is a
dramatic difference in postoperative period in regard to pain,
discomfort, and need for drugs among the different tech-
niques adopted. The first and more impressive result of our
study is the difference in the postoperative period; in fact,
patients who underwent endoscopy and LEVUR had a faster
postoperative course, less pain, and shorter period of anal-
gesic requirement compared with patients who underwent
classic open surgery.
Table 3. Postoperative Pain and Comfort Scores
for Each Group Using VAS Scale
STING
(%)
LEVUR
(%)
Cohen
(%)
Very good (VAS score 0–3) 28 (93.3) 30 (100) 0
Good (VAS score 3–7) 1 (1.11) 0 6 (20)
Bad (VAS score 7–10) 1 (1.11) 0 24 (80)
LEVUR, laparoscopic Lich-Gregoir reimplantation; STING,
subureteric injection; VAS, visual analog scale.
Table 4. Postoperative Complications and Outcome for Each Group
STING LEVUR Cohen
STING vs.
LEVUR (P)
STING vs.
Cohen (P)
LEVUR vs.
Cohen (P)
All complications 2 (6.66%) 2 (6.66%) 11 (36.6%) ns .001 .001
Fever 0 0 0 ns ns ns
UTIs 1 (3.33%) 1 (3.33%) 2 (6.66%) ns ns ns
Bleeding 0 0 0 ns ns ns
Urinoma 0 0 1 (3.33%) ns ns ns
Wound dehiscence 0 0 1 (3.33%) ns ns ns
Recurrent abdominal pain 0 0 1 (3.33%) ns ns ns
Urinary retention 0 0 1 (3.33%) ns ns ns
Nausea/vomiting 1 (3.33%) 0 4 (13.3%) ns ns .035
Reoperation 0 0 1 (3.33%) ns ns ns
Acute ureteral obstruction 0 0 1 (3.33%) ns ns ns
Stranguria 0 0 3 (10%) ns ns ns
Hematuria 0 0 28 (93.3%) ns .001 .001
Reflux persistence 10 (33.3%) 4 (13.3%) 5 (16.6%) .001 .001 ns
Intraoperative costs (Eur) 2.226 1.357 1.248 .001 .001 ns
Postoperative hospitalization costs (Eur) 1.057 1.854 6.953 ns .001 .001
LEVUR, laparoscopic Lich-Gregoir reimplantation; STING, subureteric injection; UTI, urinary tract infection; ns, not significant.
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Patients who underwent endoscopic injection and LEVUR
had no bladder catheters, ureteral stents, or drains after surgery
and no hematuria or bladder spasms, compared with the long
and painful postoperative course of open surgery. We always
preferred to leave a bladder catheter for the first 24 hours after
surgery in patients who underwent laparoscopic bilateral re-
implantation to avoid the risk of postoperative urinary reten-
tion reported in bilateral repairs. In fact, in our series, we had
only one patient who underwent bilateral Cohen reimplantation
who presented with postoperative bladder emptying difficulty,
requiring temporary urethral catheterization postoperatively.
LEVURwas not associated with bladder dysfunction as in open
surgery, even in bilateral procedures.
Cohen procedure presented significantly more compli-
cations and higher morbidity compared to LEVUR and
STING. In particular, patients who underwent open Cohen
presented with hematuria, an important pain due to bladder
spasms, urine leakages around the bladder, and needed a
drain near the bladder. In addition, they sometimes pre-
sented with catheter or stent occlusion due to the hematuria.
However, the majority of complications recorded in our
series were classified as grade II according to the Clavien–
Dindo grading system25; in fact, they resolved spontane-
ously or after medical therapy, without the need of a new
surgical procedure. Only one patient who underwent Cohen
was reoperated because of an acute ureteral obstruction
[grade III-b].
Data concerning hospitalization and postoperative mor-
bidity were all significantly better after endoscopy and
LEVUR compared to open Cohen procedure. These data
were also confirmed by the analysis of nurses’ data; in fact,
for patients operated with open technique, nurses were called
for problems or pain more times per day compared to the
assistance required by the patients who underwent LEVUR
and endoscopy. In addition, the scores recorded using the VAS
pain scale were worse after Cohen.
As for the length of surgery, endoscopy was statistically
faster compared to open surgery and LEVUR either for
unilateral or bilateral corrections.
As for the technical point of view, it seems that LEVUR is
more technically challenging for the surgeons, it requires a
skilled laparoscopic team and its learning curve is longer
compared with the other two techniques. For this reason, it is
necessary to start LEVUR experience with a mentorship
period to well master all the details of the technique.27 In our
experience with LEVUR, our learning curve plateaued and
our operative time decreased significantly after five to six
cases. We still make a video recording of all of our proce-
dures to allow the surgeons to be critical of their technique
and permit further improvement. Moreover, these advanced
laparoscopic procedures have very bad ergonomics for sur-
geons, and we recently published an article about this topic,
in which it was demonstrated that surgeons, after this kind of
procedure, take anti-inflammatory drugs to heal shoulder,
back, and wrist pain.28
Analyzing the international literature, endoscopy seems to
be more expensive compared to open surgery and LEVUR,
and this aspect is linked to the high costs of the bulking
agents.29
Responsible management of limited resources should be a
factor in choosing among different acceptable choices. For
this reason, we decided to analyze both intraoperative costs
(materials, labor, and time) and postoperative hospitalization
costs for all procedures, and we found that the intraoperative
costs were statistically higher using STING compared to the
other techniques and this difference was mainly related to the
high cost of the bulking agents. The hospitalization costs
were significantly higher after Cohen procedure and the
difference was linked to the longer hospital stay.
Reflux persistence, as already reported in the international
literature, was higher after STING compared to LEVUR and
Cohen.26 Analyzing the international literature, the success
rate using open Cohen and LEVUR is higher than 95%, while
the success rate of endoscopy after the first injection is about
75%–80%.30 This is a key point because parents ask the
surgeon mainly to heal their child and the other points of the
technique are secondary aspects for them.31
We reported a 67% success rate with STING procedure.
There are many factors that may affect the success of the
procedure. Preoperative (patient selection), intraoperative
(injection technique), and postoperative variables have been
shown to correlate with treatment outcome such as the pres-
ence of a volcano, the injected volume of the bulking agent,
the VUR grade, and the surgeon’s experience.We believe that
most failures are due to technical errors that can be avoided
intraoperatively. The technique for injection (intraureteric,
submucosal) and the means of determining the endpoint of
injection (the creation of a mountain range rather than a
mound) may be the most important of these factors. Post-
operatively, failures may result from bulking agent displace-
ment (most often caudal implant migration), disruption (bleb
loss of material through a mucosal breach), or dissolution
(decrease in implant volume). While technical failure can be
avoided, the latter three mechanisms may be inescapable.
We reviewed the reports of patients with failure of STING
procedure in our series, and we noted that all these patients
had no identifiable Dx/HA implants by ultrasonography
performed during follow-up.
Besides STING, many other methods of endoscopic in-
jection have been described in the last few years as follows:
the hydrodistention implantation technique (HIT) and then its
modification, the double HIT, described by Kirsch in 2008,
through which two tandem intraluminal ureteric tunnel in-
jections are made.32 This last method allows for relatively
higher volumes of Dx/HA to be injected (1.5 cc/ureter, de-
pending on ureteral hydrodistention grade) compared to
STING, with a mean injected volume of 0.5 cc/ureter in our
series. In 2012, Kalisvaart et al. reported that the double HIT
leads to a 93% clinical and 93% radiographic intermediate/
long-term success rate.33 In our series, we have included only
endoscopic treatments performed with STING procedure. In
ourmind, the highVURpersistence rate reportedwith STING
is due to the technical limitations of this injection method in
accordance with the other reports of the recent literature.34
Our results demonstrated that Grade reflux plays a key role
in the choice of the surgical technique; in fact, in STING
group, 50% of patients had Grade 2 VUR and only 6.7% had
Grade 5 VUR, while in Cohen group, 60% of patients had
Grade 5 VUR and 0%Grade 2 VUR. From this point of view,
LEVUR seems to be handier since it was adopted in all grades
of VUR.35
We have to also acknowledge that one limitation of our
study is that the results may be skewed by the fact that the
grade of VUR was four or five in 93% of the Cohen operation
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group compared with the 27% in the STING and 57% in the
LEVUR groups.
The results of our study demonstrated that in children af-
fected by VUR, open Cohen and LEVUR reported a high
success rate, better than STING procedure, in accordance
with the current literature. Comparing the three techniques, it
seems that LEVUR is superior to the other techniques in
terms of success (versus endoscopic injection) and postop-
erative morbidity (versus Cohen reimplantation), with a
painless postoperative period without hematuria. In addition,
it offers a good choice in terms of intraoperative and post-
operative costs, due to the short hospital stay and the use of
reusable laparoscopic instrumentation and avoiding the high
costs related to the use of the bulking agents.
In our opinion, it may be a good option for a surgical team
to manage all three techniques and to adopt one or the other
according to patient’s condition with the possibility to asso-
ciate, in case of bilateral VUR, an endoscopic procedure on
the side, with the lower degree reflux, and a LEVUR proce-
dure on the other side with the higher degree reflux.
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